Medtronic (MDT) Stock Analysis

UW

MDT Equity Research — UNDERWEIGHT — May 2026

Rating date

May 29, 2026

73 days ago

Desk view

UW

5D move

Awaiting market data

Peer rank

5p

Investment card · MDT

The most concrete company-specific catalyst in the window is the approaching Q4 earnings release (quarter ended April 2026). Zacks published a estimates-preview piece examining Wall Street's consensus for key metrics beyond revenue and E...

Desk rating

UW

Tactical UW · 12M OW

Horizon

Tactical UNDERWEIGHT · 12M OVERWEIGHT

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

UNDERWEIGHT

Catalysts

  • Dominant downtrend: All trend-following indicators (Bollinger middle, VWMA, price series) point lower. No sustained break above the 20-day SMA has occurred.
  • Momentum weakening: The brief MACD bullish crossover is unwinding; RSI is rolling over back toward oversold. Upside attempts have been sold.
  • Volatility contracting: Lower ATR suggests the recent sell-off may be decelerating, but the price continues to make lower lows.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

MDT Research Note

Full desk note for May 29, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

45 min read

WebserviceX · Agentic Research Desk

MDT Equity Research Note

Published May 29, 2026 · Desk view UNDERWEIGHT · Generated 2026-05-30T10:23:04Z · Maintained by Walter Vijayakumar · Methodology · Track record

MDT Stock Rating Summary

MDT bias

UNDERWEIGHT

Horizon

Tactical UNDERWEIGHT · 12M OVERWEIGHT

MDT key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

MDT catalyst watch

Dominant downtrend: All trend-following indicators (Bollinger middle, VWMA, price series) point lower. No sustained break above the 20-day SMA has occurred.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

Awaiting market dataPeer 5p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-05-30T11:24:23.549023+00:00.

5D move

2026-05-29 → awaiting

Outcome

Awaiting market data

5D trend

-5.55%

Vol (20D ann.)

+22.97%

vs SPY: -7.41%

Close 73.81 (USD, vendor closes)

Batch scorecard · 2026-05-29 · MDT